{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:10:09Z","timestamp":1747354209201,"version":"3.40.5"},"reference-count":21,"publisher":"American Institute of Mathematical Sciences (AIMS)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MBE"],"published-print":{"date-parts":[[2025]]},"DOI":"10.3934\/mbe.2025057","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T23:39:18Z","timestamp":1747352358000},"page":"1551-1571","source":"Crossref","is-referenced-by-count":0,"title":["Numerical analysis of critical parameter values for remission during imatinib treatment of chronic myelogenous leukemia"],"prefix":"10.3934","volume":"22","author":[{"given":"Dana","family":"Paquin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Mathematics, California Polytechnic State University, 1 Grand Ave, San Luis Obispo, CA 93407, USA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizzy","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avery","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovani","family":"Thai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2321","reference":[{"key":"key-10.3934\/mbe.2025057-1","doi-asserted-by":"publisher","unstructured":"E. Jabbour, H. Kantarjian, Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring, <i>Am. J. Hematol.<\/i>, <b>95<\/b> (2020), 691\u2013709. https:\/\/doi.org\/10.1002\/ajh.25792","DOI":"10.1002\/ajh.25792"},{"key":"key-10.3934\/mbe.2025057-2","doi-asserted-by":"publisher","unstructured":"J. Barrett, Allogeneic stem cell transplantation for chronic myeloid leukemia, <i>Semin. Hematol.<\/i>, <b>40<\/b> (2003), 59\u201371. https:\/\/doi.org\/10.1016\/S0037-1963(03)70043-2","DOI":"10.1016\/S0037-1963(03)70043-2"},{"key":"key-10.3934\/mbe.2025057-3","doi-asserted-by":"publisher","unstructured":"J. Cortes, M. Talpaz, S. O'Brien, D. Jones, R. Luthra, J. Shan, et al., Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate, <i>Clin. Cancer Res.<\/i>, <b>11<\/b> (2005), 3425\u20133432. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-2139","DOI":"10.1158\/1078-0432.CCR-04-2139"},{"key":"key-10.3934\/mbe.2025057-4","doi-asserted-by":"publisher","unstructured":"F. Michor, T. Hughes, Y. Iwasa, S. Branford, N. Shah, C. Sawyers, et al., Dynamics of chronic myeloid leukemia, <i>Nature<\/i>, <b>435<\/b> (2005), 1267\u20131270. https:\/\/doi.org\/10.1038\/nature03669","DOI":"10.1038\/nature03669"},{"key":"key-10.3934\/mbe.2025057-5","doi-asserted-by":"publisher","unstructured":"P. S. Kim, P. P. Lee, D. Levy, Dynamics and potential impact of the immune response to chronic myelogenous leukemia, <i>PLOS Comput. Biol.<\/i>, <b>4<\/b> (2008). https:\/\/doi.org\/10.1371\/journal.pcbi.1000095","DOI":"10.1371\/journal.pcbi.1000095"},{"key":"key-10.3934\/mbe.2025057-6","doi-asserted-by":"publisher","unstructured":"N. Komarova, D. Wodarz, Drug resistance in cancer: Principles of emergence and prevention, <i>Proc. Natl. Acad. Sci.<\/i>, <b>102<\/b> (2005), 9714\u20139719. https:\/\/doi.org\/10.1073\/pnas.0501870102","DOI":"10.1073\/pnas.0501870102"},{"key":"key-10.3934\/mbe.2025057-7","doi-asserted-by":"publisher","unstructured":"I. Roeder, I. Glauche, Pathogenesis, treatment effects, and resistance dynamics in chronic myeloid leukemia\u00a8Cinsights from mathematical model analyses, <i>J. Mol. Med.<\/i>, <b>86<\/b> (2008), 17\u201327. https:\/\/doi.org\/10.1007\/s00109-007-0241-y","DOI":"10.1007\/s00109-007-0241-y"},{"key":"key-10.3934\/mbe.2025057-8","doi-asserted-by":"publisher","unstructured":"I. Roeder, M. Horn, I. Glauche, A. Hochhaus, M. Mueller, M. Loeffler, Dynamic modeling of imatinib-treated chronic myeloid leukemia: Functional insights and clinical implications, <i>Nat. Med.<\/i>, <b>12<\/b> (2006), 1181\u20131184. https:\/\/doi.org\/10.1038\/nm1487","DOI":"10.1038\/nm1487"},{"key":"key-10.3934\/mbe.2025057-9","doi-asserted-by":"publisher","unstructured":"B. Werner, D. Lutz, T. H. Br\u00fcmmendorf, A. Traulsen, S. Balabanov, Dynamics of resistance development to imatinib under increasing selection pressure: A combination of mathematical models and in vitro data, <i>PLoS One<\/i>, <b>6<\/b> (2011), e28955. https:\/\/doi.org\/10.1371\/journal.pone.0028955","DOI":"10.1371\/journal.pone.0028955"},{"key":"key-10.3934\/mbe.2025057-10","doi-asserted-by":"publisher","unstructured":"S. Bunimovich-Mendrazitsky, B. Shklyar, Optimization of combined leukemia therapy by finite-dimensional optimal control modeling, <i>J. Optim. Theory Appl.<\/i>, <b>175<\/b> (2017), 218\u2013235. https:\/\/doi.org\/10.1007\/s10957-017-1161-9","DOI":"10.1007\/s10957-017-1161-9"},{"key":"key-10.3934\/mbe.2025057-11","doi-asserted-by":"publisher","unstructured":"S. Bunimovich-Mendrazitsky, N. Kronik, V. Vainstein, Optimization of interferon-Alpha and imatinib combination therapy for chronic myeloid leukemia: A modeling approach, <i>Adv. Theory Simul.<\/i>, <b>2<\/b> (2019), 1800081. https:\/\/doi.org\/10.1002\/adts.201800081","DOI":"10.1002\/adts.201800081"},{"key":"key-10.3934\/mbe.2025057-12","doi-asserted-by":"publisher","unstructured":"D. Paquin, P. S. Kim, P. Lee, D. Levy, Strategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia, <i>Bull. Math. Biol.<\/i>, <b>73<\/b> (2011), 1082\u20131100. https:\/\/doi.org\/10.1007\/s11538-010-9553-0","DOI":"10.1007\/s11538-010-9553-0"},{"key":"key-10.3934\/mbe.2025057-13","doi-asserted-by":"crossref","unstructured":"H. Smith, <i>An Introduction to Delay Differential Equations with Applications to the Life Sciences<\/i>, Springer, 2011.","DOI":"10.1007\/978-1-4419-7646-8"},{"key":"key-10.3934\/mbe.2025057-14","doi-asserted-by":"publisher","unstructured":"B. Lowenberg, Minimal residual disease in chronic myeloid leukemia, <i>N. Engl. J. Med.<\/i>, <b>349<\/b> (2003), 1399\u20131401. https:\/\/doi.org\/10.1056\/NEJMp038130","DOI":"10.1056\/NEJMp038130"},{"key":"key-10.3934\/mbe.2025057-15","doi-asserted-by":"publisher","unstructured":"D. Paquin, D. Sacco, J. Shamshoian, An analysis of strategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia with imatinib-resistant mutations, <i>Math. Biosci.<\/i>, <b>262<\/b> (2015), 117\u2013124. https:\/\/doi.org\/10.1016\/j.mbs.2015.01.011","DOI":"10.1016\/j.mbs.2015.01.011"},{"key":"key-10.3934\/mbe.2025057-16","doi-asserted-by":"publisher","unstructured":"S. Niculescu, P. Kim, K. Gu, P. Lee, D. Levy, Stability crossing boundaries of delay systems modeing immune dynamics in leukemia, <i>Discrete Contin. Dyn. Syst. - Ser. B<\/i>, <b>13<\/b> (2010), 129\u2013156. https:\/\/doi.org\/10.3934\/dcdsb.2010.13.129","DOI":"10.3934\/dcdsb.2010.13.129"},{"key":"key-10.3934\/mbe.2025057-17","doi-asserted-by":"publisher","unstructured":"A. Besse, G. Clapp, S. Bernard, F. Nicolini, D. Levy, T. Lepoutre, Stability analysis of a model of interaction between the immune system and cancer cells in chronic myelogenous leukemia, <i>Bull. Math. Biol.<\/i>, <b>80<\/b> (2018), 1084\u20131110. https:\/\/doi.org\/10.1007\/s11538-017-0272-7","DOI":"10.1007\/s11538-017-0272-7"},{"key":"key-10.3934\/mbe.2025057-18","doi-asserted-by":"publisher","unstructured":"B. Cahlon, D. Schmidt, On stability of systems of delay differential equations, <i>J. Comput. Appl. Math.<\/i>, <b>117<\/b> (2000), 137\u2013158. https:\/\/doi.org\/10.1016\/S0377-0427(99)00337-4","DOI":"10.1016\/S0377-0427(99)00337-4"},{"key":"key-10.3934\/mbe.2025057-19","unstructured":"C. T. Baker, F. A. Rihan, <i>Sensitivity Analysis of Parameters in Modelling with Delay-Differential Equations<\/i>, Manchester Centre for Computational Mathematics, 1999."},{"key":"key-10.3934\/mbe.2025057-20","doi-asserted-by":"publisher","unstructured":"F. A. Rihan, Sensitivity analysis for dynamic systems with time-lags, <i>J. Comput. Appl. Math.<\/i>, <b>151<\/b> (2003), 445\u2013462. https:\/\/doi.org\/10.1016\/S0377-0427(02)00659-3","DOI":"10.1016\/S0377-0427(02)00659-3"},{"key":"key-10.3934\/mbe.2025057-21","doi-asserted-by":"publisher","unstructured":"S. Bunimovich-Mendrazitsky, L. Shaikhet, Stability analysis of delayed tumor-antigen-activatedImmune response in combined BCG and IL-2immunotherapy of bladder cancer, <i>Processes<\/i>, <b>8<\/b> (2020), 1564. https:\/\/doi.org\/10.3390\/PR8121564","DOI":"10.3390\/PR8121564"}],"container-title":["Mathematical Biosciences and Engineering"],"original-title":[],"link":[{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/mbe.2025057?viewType=html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T23:39:22Z","timestamp":1747352362000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/mbe.2025057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3934\/mbe.2025057","relation":{},"ISSN":["1551-0018"],"issn-type":[{"value":"1551-0018","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}